AAAAAA
Results:
1-12
|
Results: 12
Authors:
HALLAK R
MUELLER J
LOTTER O
GANSAUGE S
GANSAUGE F
JUMMA ME
MONTENARH M
SAFI F
BEGER H
Citation: R. Hallak et al., P53 GENETIC ALTERATIONS, PROTEIN EXPRESSION AND AUTOANTIBODIES IN HUMAN COLORECTAL-CARCINOMA - A COMPARATIVE-STUDY, International journal of oncology, 12(4), 1998, pp. 785-791
Authors:
BACHEM MG
SCHNEIDER E
GROSS H
WEIDENBACH H
SCHMID RM
MENKE A
SIECH M
BEGER H
GRUNERT A
ADLER G
Citation: Mg. Bachem et al., IDENTIFICATION, CULTURE, AND CHARACTERIZATION OF PANCREATIC STELLATE CELLS IN RATS AND HUMANS, Gastroenterology, 115(2), 1998, pp. 421-432
Authors:
NEOPTOLEMOS JP
BAKER P
BEGER H
LINK K
PEDERZOLI P
BASSI C
DERVENIS C
FRIESS H
BUCHLER M
Citation: Jp. Neoptolemos et al., PROGRESS REPORT - A RANDOMIZED MULTICENTER EUROPEAN STUDY COMPARING ADJUVANT RADIOTHERAPY, 6-MO CHEMOTHERAPY, AND COMBINATION THERAPY, VS NO-ADJUVANT TREATMENT IN RESECTABLE PANCREATIC-CANCER (ESPAC-1), International journal of pancreatology, 21(2), 1997, pp. 97-104
Authors:
NEOPTOLEMOS JP
BUCHLER M
BEGER H
Citation: Jp. Neoptolemos et al., ESPAC SATELLITE SYMPOSIUM, Digestion, 58(6), 1997, pp. 501-502
Authors:
NEOPTOLEMOS JP
KERR DJ
BEGER H
LINK K
PEDERZOLI P
BASSI C
DERVENIS C
FERNANDEZCRUZ L
LACAINE F
FRIESS H
BUCHLER M
Citation: Jp. Neoptolemos et al., ESPAC-1 TRIAL PROGRESS REPORT - THE EUROPEAN RANDOMIZED ADJUVANT STUDY COMPARING RADIOCHEMOTHERAPY, 6 MONTHS CHEMOTHERAPY AND COMBINATION THERAPY VERSUS OBSERVATION IN PANCREATIC-CANCER, Digestion, 58(6), 1997, pp. 570-577
Authors:
SHIELDS R
BEGER H
SHELDON G
IHSE I",GOUMA
Citation: R. Shields et al., PROSPECTIVE, RANDOMIZED TRIAL ON THE EFFECT OF CYCLIC VERSUS CONTINUOUS ENTERAL NUTRITION ON POSTOPERATIVE GASTRIC FUNCTION AFTER PYLORUS-PRESERVING PANCREATICODUODENECTOMY - DISCUSSION, Annals of surgery, 226(6), 1997, pp. 685-687
Authors:
BERGMANN U
KORNMANN M
FUNATOMI H
BEGER H
KORC M
Citation: U. Bergmann et al., OVEREXPRESSION OF INSULIN-RECEPTOR SUBSTRATE-1 OCCURS FREQUENTLY IN HUMAN PANCREATIC CANCERS, Gastroenterology, 110(4), 1996, pp. 378-378
Authors:
RILINGER N
GANZAUGE F
LINK KH
GOERICH J
BEGER H
BRAMBS HJ
Citation: N. Rilinger et al., LOCAL CYTOTOXIC THERAPY IN ADVANCED PANCREATIC-CANCER - EXPERIENCE WITH 210 PROCEDURES, Radiology, 197, 1995, pp. 379-379
Authors:
GRESS TM
MULLERPILLASCH F
LERCH MM
BEGER H
FRIESS H
BUCHLER M
ADLER G
Citation: Tm. Gress et al., EXPRESSION OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN PANCREATIC-CARCINOMA AND CHRONIC-PANCREATITIS, Gastroenterology, 108(4), 1995, pp. 476-476
Authors:
LIMMER J
ELLBRUCK D
MULLER H
EISELE E
RIST J
SCHUTZE F
BEGER H
HEIMPEL H
SEIFRIED E
Citation: J. Limmer et al., PROSPECTIVE RANDOMIZED CLINICAL-STUDY IN GENERAL-SURGERY COMPARING A NEW LOW-MOLECULAR-WEIGHT HEPARIN WITH UNFRACTIONATED HEPARIN IN THE PREVENTION OF THROMBOSIS, The Clinical investigator, 72(11), 1994, pp. 913-919
Authors:
FRIESS H
YAMANAKA Y
KOBRIN MS
BUCHLER M
BEGER H
KORC M
Citation: H. Friess et al., CYTOCHEMICAL AND MOLECULAR EVIDENCE FOR THE OVEREXPRESSION OF ACIDIC FIBROBLAST GROWTH-FACTOR IN THE CANCEROUS HUMAN PANCREAS, Gastroenterology, 104(4), 1993, pp. 304-304
Authors:
YAMANAKA Y
FRIESS H
KOBRIN MS
BUCHLER M
BEGER H
KORC M
Citation: Y. Yamanaka et al., OVEREXPRESSION OF THE C-ERB B-2 ONCOGENE IN HUMAN PANCREATIC CARCINOMAS CORRELATES WITH WELL-DIFFERENTIATED HISTOLOGICAL GRADING, Gastroenterology, 104(4), 1993, pp. 344-344
Risultati:
1-12
|